Key result
The CYP11B2 T/T genotype was significantly more prevalent in elderly patients with atrial fibrillation and coronary heart disease compared to healthy controls (38.1% vs 14.7%; OR 3.44, p=0.038).
Why the study?
Given the rising frequency of AF in elderly patients with CHD, evaluating the role of renin-angiotensin-aldosterone system polymorphisms, specifically the CYP11B2 gene, became relevant.
Does the CYP11B2 T/T genotype increase the risk of atrial fibrillation in elderly patients with coronary heart disease?
Case-Control (n=118)
Does the CYP11B2 T/T genotype increase the risk of atrial fibrillation in elderly patients with coronary heart disease?
Odds Ratio: 3.44 (95% CI 1.07–11.07)
Absolute Event Rate: 38.1% vs 14.7%
p-value: p=0.038
The CYP11B2 T/T genotype is significantly associated with the presence of atrial fibrillation in elderly patients with coronary heart disease.
CYP11B2 T/T genotype was associated with AF in elderly CHD patients; leaves open whether genotyping aids risk stratification or requires prospective validation.
Given the significant increase in the frequency of atrial fibrillation (AF) in elderly and senile patients with confirmed coronary heart disease (CHD), the study of the relationship between the polymorphisms responsible for the functioning of the renin-angiotensinaldosterone system and the presence of this disease becomes relevant. Purpose of the study. To study the genetic polymorphism of the CYP11B2 gene in elderly patients with ischemic heart disease, as well as to identify the role of aldosterone synthetase in the development of AF in this category of patients. Materials and methods. The study included 140 patients of both sexes (54,3% – men), over the age of 60 years, with confirmed coronary artery disease and any form of AF (the last episode no later than 12 months from the date of inclusion in the study). 84 patients agreed to participate in the study of aldosterone synthase polymorphisms. The control group consisted of 34 patients who had no diagnosed non-infectious diseases at the time of the survey. Both groups were comparable in age and sex characteristics. Results. Comparative evaluation of the distribution of genotypes and alleles – C344/T of the aldosterone synthase gene among patients with AF+CHD and relatively healthy individuals revealed that in the first group, most patients had the CYP11B2 T/T genotype in 38,1% of cases, the incidence was higher, than in patients of the comparison group – 14,7% (OR = 3.44, CI 1.07-11.07, p = 0.038). The frequency of detection of genotypes of CYP11B2 С/T and CYP11B2 С/С did not significantly differ in the compared groups. In the group with AF+CHD, the T allele was significantly more common (53,6% vs. 35,3%; p<0,05), while the frequency of occurrence of allele C was significantly higher in the group of relatively healthy individuals (64,3% vs. 47,1%; p<0,05). Conclusion. AF in elderly and senile patients with CHD is associated with the presence of CYP11B2 T/T genotype (OR = 3,44, DI 1,07–11,07, p = 0,038) and is not associated with myocardial echocardiographic parameters, including the size of left atrium.
No takes yet. Share an insight, caveat, or question.
Kudryavtseva et al. (2019) conducted a case-control in Atrial fibrillation and coronary heart disease (n=118). CYP11B2 T/T genotype vs. Healthy controls (without non-infectious diseases) was evaluated on Frequency of CYP11B2 T/T genotype (OR 3.44, 95% CI 1.07-11.07, p=0.038). The CYP11B2 T/T genotype was significantly more prevalent in elderly patients with atrial fibrillation and coronary heart disease compared to healthy controls (38.1% vs 14.7%; OR 3.44, p=0.038).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: